newsfilter
← Latest News
GlobeNewswire·

Diffusion Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

Announces Intent to Develop TSC to Treat Hypoxic Tumors Altitude Trial Expected to Commence in November 2021 ILD-DLCO Trial Expected to Commence in Late December 2021 CHARLOTTESVILLE, Va., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharma